Literature DB >> 17604067

Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception?

Carlos Eugênio Cavasini1, Luiz Carlos de Mattos, Alvaro Augusto D'Almeida Couto, Cláudia Regina Bonini-Domingos, Socrates Herrera Valencia, Wanessa Christina de Souza Neiras, Renata Tomé Alves, Andréa Regina Baptista Rossit, Lilian Castilho, Ricardo Luiz Dantas Machado.   

Abstract

We present evidence for Plasmodium vivax infection among Duffy blood group-negative inhabitants of Brazil. The P. vivax identification was determined by both genotypic and non-genotypic screening tests. The Duffy blood group was genotyped by PCR/RFLP and phenotyped using a microtyping kit. We detected two homozygous FY*B-33 carriers infected by P. vivax, whose circumsporozoite protein genotypes were VK210 and/or P. vivax-like. Additional efforts are necessary in order to clarify the evidence that P. vivax is being transmitted among Duffy blood group-negative patients from the Brazilian Amazon region.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604067     DOI: 10.1016/j.trstmh.2007.04.011

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  56 in total

Review 1.  Molecular basis of the Duffy blood group system.

Authors:  Gabriela Höher; Marilu Fiegenbaum; Silvana Almeida
Journal:  Blood Transfus       Date:  2017-01-30       Impact factor: 3.443

Review 2.  Plasmodium vivax Infections of Duffy-Negative Erythrocytes: Historically Undetected or a Recent Adaptation?

Authors:  Karthigayan Gunalan; Amadou Niangaly; Mahamadou A Thera; Ogobara K Doumbo; Louis H Miller
Journal:  Trends Parasitol       Date:  2018-03-09

3.  Uncertainty in mapping malaria epidemiology: implications for control.

Authors:  David Sullivan
Journal:  Epidemiol Rev       Date:  2010-06-25       Impact factor: 6.222

4.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 5.  Molecular interactions governing host-specificity of blood stage malaria parasites.

Authors:  Erik J Scully; Usheer Kanjee; Manoj T Duraisingh
Journal:  Curr Opin Microbiol       Date:  2017-10-31       Impact factor: 7.934

6.  Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.

Authors:  Karthigayan Gunalan; Eugenia Lo; Jessica B Hostetler; Delenasaw Yewhalaw; Jianbing Mu; Daniel E Neafsey; Guiyun Yan; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

Review 7.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

8.  The international limits and population at risk of Plasmodium vivax transmission in 2009.

Authors:  Carlos A Guerra; Rosalind E Howes; Anand P Patil; Peter W Gething; Thomas P Van Boeckel; William H Temperley; Caroline W Kabaria; Andrew J Tatem; Bui H Manh; Iqbal R F Elyazar; J Kevin Baird; Robert W Snow; Simon I Hay
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

9.  Natural selection for the Duffy-null allele in the recently admixed people of Madagascar.

Authors:  Jason A Hodgson; Joseph K Pickrell; Laurel N Pearson; Ellen E Quillen; António Prista; Jorge Rocha; Himla Soodyall; Mark D Shriver; George H Perry
Journal:  Proc Biol Sci       Date:  2014-08-22       Impact factor: 5.349

Review 10.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.